SEC Form 4 · accession 0001104659-18-068789
Ra Pharmaceuticals, Inc. · RARX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander Cumbo
Director
Period of report
Nov 14, 2018
Accepted (ET)
Nov 15, 2018 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001481512
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $12.99 | Nov 14, 2018 | A | 25,000 | A | — | Nov 14, 2028 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1On November 14, 2018, the Reporting Person was granted an option to purchase 25,000 shares of Common Stock. The option will vest and become exercisable in three equal installments on each of November 14, 2019, November 14, 2020 and November 14, 2021.